peoplePerson
Alan P. Venook
GI oncologist who led CALGB/SWOG 80405 and helped show that tumour side matters in colorectal cancer.
Alan Venook is a medical oncologist and long-time Alliance investigator. Chaired CALGB/SWOG 80405, the first-line cetuximab versus bevacizumab trial whose analyses established primary tumour sidedness as a treatment factor.
Role
Shorenstein Associate Director for Program Development, UCSF Helen Diller Family Comprehensive Cancer Center
Specialisms
Colorectal cancerLiver cancerCooperative group trials
Profiles
Pages like this
not linked directly; found by shared links- PersonEmily K. Bergsland
Shares UCSF Helen Diller Family Comprehensive Cancer Center, VEGF / VEGFR.
- InstitutionNational Taiwan University Hospital
Shares VEGF / VEGFR, EGFR, Hepatocellular carcinoma, Colorectal cancer.
- PersonMatthew Meyerson
Shares EGFR, Colorectal cancer.
- CompanySirtex Medical
- TrialATOMIC (Alliance A021502)
Shares Alliance for Clinical Trials in Oncology, Colorectal cancer.
- PersonFrank McCormick
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Colorectal cancer.
- CompanyBoston Scientific
- IdeaKeep a freshly removed tumour alive on a pump and test drugs in it